K Piil1, J Jakobsen2, M Juhler3, M Jarden4. 1. Rigshospitalet, University of Copenhagen, Dept. of Neurosurgery, Blegdamsvej 9, 2100 Copenhagen, Denmark; The University Hospitals Center for Health Research (UCSF) and Center for Integrated Rehabilitation of Cancer Patients (CIRE), Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: Karin.piil@regionh.dk. 2. Rigshospitalet, University of Copenhagen, Neuroscience Center, Blegdamsvej 9, 2100 Copenhagen, Denmark. 3. Rigshospitalet, University of Copenhagen, Dept. of Neurosurgery, Blegdamsvej 9, 2100 Copenhagen, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Institute of Clinical Medicine, Section of Neurology, Psychiatry and Sensory Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark. 4. The University Hospitals Center for Health Research (UCSF) and Center for Integrated Rehabilitation of Cancer Patients (CIRE), Blegdamsvej 9, 2100 Copenhagen, Denmark.
Abstract
PURPOSE:Patients with a high-grade glioma (HGG) and their caregivers have imminent and changing informational and supportive care needs. The purpose of this study was to investigate the feasibility and safety of a Danish brain tumour website (BTW) in patients with HGG and their caregivers. We hypothesized that the BTW would be feasible, safe, helpful and convenient for individuals to obtain support and information. METHODS: This is an exploratory, prospective six-month feasibility study. Two separate samples were collected: 1) a nationwide sample consisting of BTW visitors over a six-month period and2) a sample of patients with HGG (n = 9) and their caregivers (n = 8) interviewed three months after being introduced to the BTW. RESULTS: The BTW was accessed from 131 different Danish towns and cities, and from ten different countries. The website had 637 unique users. The interviews identified one overarching theme 'challenges and barriers'. Being newly diagnosed, patients described a chaotic and overwhelming life situation and had difficulties in identifying with their new and changed role. When using the BTW, some patients and caregivers experienced technological challenges, while the former also experienced cognitive difficulties. Caregivers greatly appreciated that the BTW was available and that easily accessible specialists could answer their questions. CONCLUSION: The BTW attracted nationwide interest and activity, but the burden of being newly diagnosed with HGG combined with a low level of internet skills and cognitive deficits were barriers to participation. TRIAL REGISTRATION NUMBER: ISRCTN22038059.
RCT Entities:
PURPOSE:Patients with a high-grade glioma (HGG) and their caregivers have imminent and changing informational and supportive care needs. The purpose of this study was to investigate the feasibility and safety of a Danish brain tumour website (BTW) in patients with HGG and their caregivers. We hypothesized that the BTW would be feasible, safe, helpful and convenient for individuals to obtain support and information. METHODS: This is an exploratory, prospective six-month feasibility study. Two separate samples were collected: 1) a nationwide sample consisting of BTW visitors over a six-month period and 2) a sample of patients with HGG (n = 9) and their caregivers (n = 8) interviewed three months after being introduced to the BTW. RESULTS: The BTW was accessed from 131 different Danish towns and cities, and from ten different countries. The website had 637 unique users. The interviews identified one overarching theme 'challenges and barriers'. Being newly diagnosed, patients described a chaotic and overwhelming life situation and had difficulties in identifying with their new and changed role. When using the BTW, some patients and caregivers experienced technological challenges, while the former also experienced cognitive difficulties. Caregivers greatly appreciated that the BTW was available and that easily accessible specialists could answer their questions. CONCLUSION: The BTW attracted nationwide interest and activity, but the burden of being newly diagnosed with HGG combined with a low level of internet skills and cognitive deficits were barriers to participation. TRIAL REGISTRATION NUMBER: ISRCTN22038059.
Authors: Florien W Boele; Cornelia F van Uden-Kraan; Karen Hilverda; Jaap C Reijneveld; Wilmy Cleijne; Martin Klein; Irma M Verdonck-de Leeuw Journal: Support Care Cancer Date: 2016-02-15 Impact factor: 3.603
Authors: Florien W Boele; Cornelia F van Uden-Kraan; Karen Hilverda; Jason Weimer; Heidi S Donovan; Jan Drappatz; Frank S Lieberman; Irma Verdonck-de Leeuw; Paula R Sherwood Journal: J Neurooncol Date: 2017-05-26 Impact factor: 4.130
Authors: William Sage; Rocío Fernández-Méndez; Anna Crofton; Michael J Gifford; Alexey Bannykh; Constantinos Chrysaphinis; Emma Tingley; Helen Bulbeck; Mita Brahmbhatt; John D Pickard; Fiona M Walter; Andrew Brodbelt; Stephen J Price; Alexis J Joannides Journal: Cancer Manag Res Date: 2019-03-19 Impact factor: 3.989
Authors: L D de Hosson; G Bouma; J Stelwagen; H van Essen; G H de Bock; D J A de Groot; E G E de Vries; A M E Walenkamp Journal: Orphanet J Rare Dis Date: 2019-02-28 Impact factor: 4.123